Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease

NCT02264288 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

159

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision with all subjects completing at least 1 year follow-up

Conditions

Peripheral Arterial Disease
Diabetic Foot

Interventions

BIOLOGICAL: 3 x 10^6 cells
BIOLOGICAL: 10 x 10^6 cells
BIOLOGICAL: 30 x 10^6 cells
OTHER: Placebo

Sponsor

Celularity Incorporated